About Holly Archer

This author has not yet filled in any details.
So far Holly Archer has created 19 blog entries.

Tony Cates joins Cycle Group Holdings Board of Directors

By |2021-10-06T10:39:32+01:00October 6th, 2021|News, Nityr|

Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE)

By |2021-09-28T11:36:58+01:00September 28th, 2021|News, Nityr|

Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients

By |2021-09-14T16:56:52+01:00September 10th, 2021|News, Nityr|

Cycle Pharmaceuticals appoints Steve McCue as Chief Financial Officer

By |2021-05-25T17:41:24+01:00May 25th, 2021|Corporate, News|

Dr Alejandra Bruna joins Cycle Group Holdings Board of Directors

By |2021-05-17T18:52:30+01:00April 29th, 2021|News, Nityr|

NITYR (nitisinone) Tablets for Tyrosinaemia Type 1 receives Marketing Authorization in New Zealand

By |2021-05-17T18:52:30+01:00March 15th, 2021|News, Nityr|

Cycle Announces the Appointment of Angela Kurtz as Clinical Metabolic Director to lead its newly created Clinical Metabolic Department

By |2021-05-17T18:52:30+01:00December 2nd, 2020|Generics, News|

US FDA Grants Once Daily Dosing Option For NITYR (nitisinone) Tablets for HT-1 Patients

By |2021-05-17T18:52:30+01:00September 14th, 2020|Generics, News|

Dr David Buckeridge Joins Cycle Group Holdings’ Board of Directors

By |2021-05-17T18:52:31+01:00September 8th, 2020|Generics, News|

Cycle Pharmaceuticals Features in the Sunday Times Tech Track Ones to Watch 2020

By |2021-05-17T18:52:31+01:00September 8th, 2020|Generics, News|
Go to Top